MEDIGENA
ActiveSummary
MEDIGENA has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,000 and a net result of €14,379. Equity is shrinking by about 2.9% per year across the filed financial years. Its solvency ranks better than 11% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| BALLARD Sandra Madeleine Jeanne |
|
| MG BALTHAZAR ET BALLARD |
|
Owners and capital
Owners
1 ownerChain of control
- MG BALTHAZAR ET BALLARD
- MEDIGENA
Highest known parent: MG BALTHAZAR ET BALLARD. The sources do not say who stands above it.
Owners 1
-
100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- MG BALTHAZAR ET BALLARD (BE 0886.755.489) sole founder · 100% at incorporation
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 04-07-2023 Incorporation · €30,000